Moreover, the gene’s involvement in RCC is associated with the formation of G-quadruplex structures, a non-B DNA.[77] This evidence suggests that targeting IGFN1 could have a therapeutic potential in the context of RCC, making it an intriguing candidate for further investigation and intervention in cancer treatment. The gene discussed is IGFN1; the disease is renal cell carcinoma.